Bingham, Clifton O.

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working Group, Puzanov, I., Diab, A., Abdallah, K., Bingham, C. O., Brogdon, C., Dadu, R., Hamad, L., Kim, S., Lacouture, M. E., et al. (2017) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 1,992

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine

Osteoarthritis Treatment and MechanismsMusculoskeletal pain and rehabilitation

Cited by 1,329

Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0

Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology

Delphi Technique in ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 781

Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial

Bingham, C. O., Looney, R. J., Deodhar, A., Halsey, N., Greenwald, M., Codding, C., Trzaskoma, B., Martin, F., Agarwal, S., & Kelman, A. (2010) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesImmunodeficiency and Autoimmune Disorders

Cited by 459

IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis

Faust, H. J., Zhang, H., Han, J., Wolf, M. T., Jeon, O. H., Sadtler, K., Peña, A. N., Chung, L., Maestas, D. R., Tam, A. J., et al. (2020) · Journal of Clinical Investigation

Osteoarthritis Treatment and MechanismsTelomeres, Telomerase, and Senescence

Cited by 260

Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

Braaten, T. J., Brahmer, J. R., Forde, P. M., Le, D., Lipson, E. J., Naidoo, J., Schollenberger, M., Zheng, L., Bingham, C. O., Shah, A. A., et al. (2020) · Annals of the Rheumatic Diseases

Cancer Immunotherapy and BiomarkersRheumatoid Arthritis Research and Therapies

Cited by 230

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

Winthrop, K. L., Silverfield, J., Racewicz, A., Neal, J., Lee, E. B., Hrycaj, P., Gomez-Reino, J., Soma, K., Mebus, C., Wilkinson, B., et al. (2016) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesImmunotoxicology and immune responses

Cited by 196

Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions

Bingham, C. O., & Moni, M. (2013) · Current Opinion in Rheumatology

Oral microbiology and periodontitis researchRheumatoid Arthritis Research and Therapies

Cited by 174

Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis

Cappelli, L. C., Dorak, M. T., Bettinotti, M. P., Bingham, C. O., & Shah, A. A. (2019) · Rheumatology

Rheumatoid Arthritis Research and TherapiesCancer Immunotherapy and Biomarkers

Cited by 111

Yoga in Sedentary Adults with Arthritis: Effects of a Randomized Controlled Pragmatic Trial

Moonaz, S. H., Bingham, C. O., Wissow, L., & Bartlett, S. J. (2015) · The Journal of Rheumatology

Physical Activity and HealthMusculoskeletal pain and rehabilitation

Cited by 98

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology

Beaton, D. E., Maxwell, L. J., Shea, B. J., Wells, G. A., Boers, M., Grosskleg, S., Bingham, C. O., Conaghan, P. G., D’Agostino, M. A., de Wit, M. P., et al. (2019) · The Journal of Rheumatology

Delphi Technique in ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 96

Mast-cell responses in the development of asthma

Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology

Mast cells and histamineAsthma and respiratory diseases

Cited by 80

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

Alten, R., Bingham, C. O., Cohen, S. B., Curtis, J. R., Kelly, S., Wong, D., & Genovese, M. C. (2016) · BMC Musculoskeletal Disorders

Rheumatoid Arthritis Research and TherapiesPneumonia and Respiratory Infections

Cited by 75

Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy

Winthrop, K. L., Bingham, C. O., Komocsar, W. J., Bradley, J., Issa, M., Klar, R., & Kartman, C. E. (2019) · Arthritis Research & Therapy

Rheumatoid Arthritis Research and TherapiesImmunotoxicology and immune responses

Cited by 61

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)

Aletaha, D., Bingham, C. O., Karpouzas, G. A., Takeuchi, T., Thorne, C., Bili, A., Agarwal, P., Hsu, B., Rao, R., Brown, K., et al. (2021) · RMD Open

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 20